The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial

類似資料

• Effect of Risedronate on Hip Structural Geometry: A 1-Year, Double-Blind Trial in Chemotherapy-Induced Postmenopausal Women
  著者:: van Londen, G. J., 等
  出版事項: (2008)
• The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer
  著者:: van Londen, G. J., 等
  出版事項: (2010)
• Risedronate’s Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
  著者:: Gates, Brian J., 等
  出版事項: (2012)
• Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
  著者:: Greenspan, Susan L., 等
  出版事項: (2008)
• Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal women
  著者:: Ali, Asma, 等
  出版事項: (2017)